A detailed history of Invenire Partners, LP transactions in Apyx Medical Corp stock. As of the latest transaction made, Invenire Partners, LP holds 945,711 shares of APYX stock, worth $1.16 Million. This represents 100.0% of its overall portfolio holdings.

Number of Shares
945,711
Previous 577,953 63.63%
Holding current value
$1.16 Million
Previous $3.39 Million 125305.85%
% of portfolio
100.0%
Previous 4.91%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$4.49 - $10.83 $1.65 Million - $3.98 Million
367,758 Added 63.63%
945,711 $4.25 Billion
Q2 2022

Aug 15, 2022

BUY
$3.11 - $7.5 $519,226 - $1.25 Million
166,954 Added 40.62%
577,953 $3.39 Million
Q1 2022

May 13, 2022

BUY
$5.87 - $13.13 $369,763 - $827,084
62,992 Added 18.1%
410,999 $2.68 Million
Q4 2021

Feb 14, 2022

BUY
$12.15 - $17.4 $4.23 Million - $6.06 Million
348,007 New
348,007 $4.46 Million

Others Institutions Holding APYX

About Apyx Medical Corp


  • Ticker APYX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 34,573,000
  • Market Cap $42.5M
  • Description
  • Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ab...
More about APYX
Track This Portfolio

Track Invenire Partners, LP Portfolio

Follow Invenire Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invenire Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Invenire Partners, LP with notifications on news.